As a result, many not-for-profit hospitals and their contract pharmacies are using the program to generate millions in revenue by selling the 340B drugs to patients covered by employer-sponsored health coverage at high retail prices.https://t.co/22WV8Sga6e
PBMs were initially designed to negotiate lower drug costs on behalf of patients. But in reality, these companies, now some of the most powerful entities in the health care system, often increase, rather than reduce, what patients pay. https://t.co/msHg9MQGtB
Across the nation, hospitals are turning taxpayer-funded discounts into executive bonuses, and other questionable expenditures, while patient struggle to afford their medications. https://t.co/9Fb6DCvVL5
The crux of the problem is that the IRA imposes price caps that shorten the effective life of a patent and applies those price controls even to later-approved uses. https://t.co/9xaO7ZqxMa
He argued the most effective way for Republicans to counter Democrats’ health care messaging is to change the subject and pivot to reducing drug prices in tandem with Trump. https://t.co/2ro70oIolc
"A PBM can act as a wholesaler, pharmacy, benefit designer & even a manufacturer. Vertical integration has given insurers control over the supply chain long before a medication reaches a patient. Lawmakers should include PBM reform in the year-end pkg." https://t.co/36WBXC5Qpg
"The opacity & misaligned incentives that plague the PBM market are currently harming patients. PBMs have reduced the efficiency of the marketplace, diverting billions toward supply chain middlemen, increasing costs on employers, consumers & taxpayers." https://t.co/0csFXvIX9U
As the first wave of negotiated Medicare Part D drug prices takes effect in January 2026, drug pricing experts say complicated subplots are brewing beneath the surface of the overall story of lower drug prices. https://t.co/H7in9qs78f
PBMs continue to benefit from a system initially established to help patients and the costs associated with their lifesaving drugs. https://t.co/F5nNlEcO86
PBM reform, on the other hand, strikes at the actual source of price distortion. Congress has an opportunity to learn from multiple states and act on this front. https://t.co/1BJp41WFCX
About 1,100 licensed Pennsylvania pharmacies went out of business from early 2020 to early November of this year, according to Department of State records. While some new ones opened, the data showed a net loss of hundreds of pharmacies. https://t.co/8xs3ItlCsV
So, it’s especially frustrating to see some families working hard to stay healthy while big hospitals exploit them. They shouldn’t be paying inflated prices for medications that hospitals acquired at steep discounts. https://t.co/A8lBo8BwBK
“When I started working here, nobody knew what a PBM is,��� Basrai said. “When I go to D.C., you don’t even have to explain it anymore.” https://t.co/9J8IoPfFwN
The American Hospital Association and several hospital systems have filed a lawsuit seeking to halt an upcoming pilot program that would alter payments for medicines purchased through a controversial federal drug discount program. https://t.co/Rr11pYON00